Filing Flows › Comparisons › SLN vs SCNX
Silence Therapeutics vs Scienture Holdings: SLN and SCNX compared
Silence Therapeutics is the larger company: $422K of revenue in its latest quarter (Q1 2026) against $344K for Scienture Holdings (Q2 2026).
Where the money goes: SLN and SCNX
Silence Therapeutics (SLN) · Q1 2026
Silence Therapeutics, Q1 2026: revenue $422K (+197% year over year), net loss $15.0M, operating cash flow −$15.6M. The chart follows the revenue to costs, profit and cash.
Scienture Holdings (SCNX) · Q2 2026
Scienture Holdings, Q2 2026: revenue $344K, operating margin -785.6%, net loss $2.8M, operating cash flow −$3.1M. The chart follows the revenue to costs, profit and cash.
| Silence Therapeutics (SLN) | Scienture Holdings (SCNX) | |
|---|---|---|
| Latest quarter | Q1 2026 | Q2 2026 |
| Revenue | $422K | $344K |
| Revenue growth, Y/Y | +197% | — |
| Operating margin | n/m | -785.6% |
| Net earnings | −$15.0M | −$2.8M |
| Net margin | — | -821.3% |
| Operating cash flow | −$15.6M | −$3.1M |
Questions
Which is bigger, Silence Therapeutics or Scienture Holdings?
Silence Therapeutics is the larger company: $422K of revenue in its latest quarter (Q1 2026) against $344K for Scienture Holdings (Q2 2026).
More: Silence Therapeutics earnings · how Silence Therapeutics makes money · Scienture Holdings earnings · how Scienture Holdings makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed May 7, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.